To determine whether the activation of JNK/p38 MAPK by DB treatment promotes apoptosis, CRC cells were pre-treated with either the JNK MAPK inhibitor, SP600125, or SB20358, an inhibitor of p38 MAPK, for 3 h before DB treatment. Here, MAPK8 is linked to colorectal carcinoma.